JDRF is the world's largest charitable supporter of type 1 diabetes research.
JDRF was founded in 1970 in the US and 1982 in Australia by a group of determined volunteers.
Internationally, JDRF has been involved in every major type 1 diabetes breakthrough of the last four decades. JDRF-funded researchers have driven the advancement of day-to-day disease management tools and accelerated the pace of research through a focus on four research priorities - immune therapies, beta cell therapies, glucose control therapies and complications therapies.
JDRF supports Australian diabetes research via the strategic provision of funding, investing over $160 million into Australian research to date.
In addition to supporting research, JDRF Australia plays a key role in advising and influencing health policy direction across all levels of government and building community awareness of type 1 diabetes.
Throughout all local and international activities JDRF's mission remains constant - to find a cure for type 1 diabetes and its complications through the support of research.